Patents by Inventor Andrew Raymond Peters

Andrew Raymond Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral vaccine for peste-des-petits-ruminants virus
    Patent number: 11850280
    Abstract: The inventive subject matter includes a viral-vectored composition made of a bacterial expression vehicle expressing one or more recombinant viral protein antigens and its method of use. In particular, this invention relates to a vaccine for oral administration. Preferably, the bacterial expression vehicle is Bacillus subtilis.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: December 26, 2023
    Assignee: US Biologic, Inc
    Inventors: Jolieke Gerdy van Oosterwijk, Andrew Raymond Peters, Douglas Steven Zatechka, Jr., Luciana Meirelles Richer, Christopher Anthony Przybyszewski
  • Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle
    Patent number: 7056492
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis (M. bovis) by administering to the animal an effective amount of a Mycoplasma hyopneumoniae (M. hyo) vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: June 6, 2006
    Assignee: Pfizer Inc.
    Inventors: Alexander C. Goudie, Andrew Raymond Peters, Robin Lee Keich
  • Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
    Publication number: 20030064079
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis (M. bovis) by administering to the animal an effective amount of a Mycoplasma hyopneumoniae (M. hyo) vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Application
    Filed: June 20, 2002
    Publication date: April 3, 2003
    Applicant: Pfizer Inc.
    Inventors: Alexander C. Goudie, Andrew Raymond Peters, Robin Lee Keich